Overcoming Therapeutic Inertia with Inhaled Insulin Therapy
Abstract
Despite the known acute and chronic complications associated with suboptimal glycemic control, only approximately 25% of people with type 1 diabetes and type 2 diabetes who are treated with prandial insulin are achieving the American Diabetes Association-recommended glycated hemoglobin target of
Fields of Study & Subjects
Inhalation and Respiratory Drug Delivery
Diabetes Management and Research
Asthma and respiratory diseases
Publication details
- Journal / source
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Volume
- 28
- Issue
- 1_suppl
- Pages
- 70S–76S
- Publication date
- 1 February 2026
- Language
- EN